A high concentration of lactic acid in the tumor microenvironment disrupts the [H+] gradient between T cells and their environment, reducing the monocarboxylate transporter 1 (MCT1)-mediated export of lactic acid from T cells. The gene discussed is SLC16A1; the disease is neoplasm.